Gene therapy treatment for blood disease approved in Europe

Genetically modification of humans has been been approved for the first time in Europe. Swiss-based biotech company Crispr Therapeutics hope to find a way of curing blood disease beta thalassaemia....

[[ This is a content summary only. Visit my website for full links, other content, and more! ]]